Covered recipient · General Payments record
KAI H YANG
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$10,254.57
- Reported across 638 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $328.35 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $125.00 | 1 |
| Abbott Laboratories | $50.95 | 3 |
| Novo Nordisk AS | $34.21 | 2 |
| ABBVIE INC. | $33.75 | 2 |
| Medtronic, Inc. | $24.78 | 1 |
| IBSA Pharma Inc. | $24.52 | 1 |
| Insulet Corporation | $21.95 | 1 |
| Lilly USA, LLC | $13.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.45 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124842911 | CMS |
| Abbott Laboratories | $19.59 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124842915 | CMS |
| Abbott Laboratories | $13.91 | 11/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124842919 | CMS |
| ABBVIE INC. | $20.54 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106370584 | CMS |
| ABBVIE INC. | $13.21 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106370586 | CMS |
| Amgen Inc. | $125.00 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111743828 | CMS |
| IBSA Pharma Inc. | $24.52 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142977646 | CMS |
| Insulet Corporation | $21.95 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116794263 | CMS |
| Lilly USA, LLC | $13.19 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135075825 | CMS |
| Medtronic, Inc. | $24.78 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117062461 | CMS |
| Novo Nordisk Inc | $14.58 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097763969 | CMS |
| Novo Nordisk Inc | $19.63 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097109934 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.